UnitedHealth, Hemsley and Annual Pay
Digest more
Even UnitedHealth will struggle to overcome parasitic medical costs that Warren Buffett once called a tapeworm eating away at U.S. economic competitiveness. The $300 billion healthcare conglomerate reinstalled Chairman Stephen Hemsley as CEO and yanked its financial guidance.
Surging medical costs and regulatory changes hit UnitedHealth, but rivals such as Humana and CVS look better positioned.
Nvidia and AMD extend gains after the chip makers sign deals with Saudi Arabia, UnitedHealth claws back some losses from the previous session, and American Eagle Outfitters slumps after pulling guidance for the rest of the fiscal year.
The White House unveiled what it says is $600bn worth of defence and artificial intelligence deals with Saudi Arabia, UnitedHealth Group shares sink to the lowest level in more than four years, and US inflation fell to 2.3 per cent in April. Plus, Nissan plans to axe 15 per cent of its global workforce and almost halve its number of plants.
May 13 (UPI) -- UnitedHealth Group announced Tuesday CEO Andrew Witty will step down, citing "personal reasons." Witty will leave the role of CEO and be replaced by Stephen J. Hemsley, effective immediately.
Explore more
UnitedHealth has been hammered in a number of ways: increased costs, political pressure over its size, and scrutiny by the Federal Trade Commission and Department of Justice. Cong
UnitedHealth Group Chief Executive Officer Andrew Witty stepped down, effective immediately, "for personal reasons", the company said Tuesday. “Leading the people of UnitedHealth Group has been a tremendous honor as they work every day to improve the health system, and they will continue to inspire me,” Witty said in a statement shared by UHG.
Shares of UnitedHealth Group sank sharply on Tuesday as the health insurance giant replaced its CEO and suspended its 2025 outlook.
UnitedHealth Group CEO Andrew Witty has stepped down unexpectedly and company veteran Stephen Hemsley is returning to the top role to steer the healthcare conglomerate through one of its most challenging periods.